BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31262833)

  • 1. Poly Combs the Immune System: PRC2 Loss in Malignant Peripheral Nerve Sheath Tumors Can Dampen Immune Responses.
    Natarajan SK; Venneti S
    Cancer Res; 2019 Jul; 79(13):3172-3173. PubMed ID: 31262833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors.
    Wojcik JB; Marchione DM; Sidoli S; Djedid A; Lisby A; Majewski J; Garcia BA
    Cancer Res; 2019 Jul; 79(13):3205-3219. PubMed ID: 30898839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
    Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
    Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors.
    Thangaiah JJ; Westling BE; Roden AC; Giannini C; Tetzlaff M; Cho WC; Folpe AL
    Ann Diagn Pathol; 2022 Aug; 59():151967. PubMed ID: 35567887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
    Lyskjaer I; Lindsay D; Tirabosco R; Steele CD; Lombard P; Strobl AC; Rocha AM; Davies C; Ye H; Bekers E; Ingruber J; Lechner M; Amary F; Pillay N; Flanagan AM
    J Pathol; 2020 Oct; 252(2):151-164. PubMed ID: 32666581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
    Zhang X; Murray B; Mo G; Shern JF
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.
    Marchione DM; Lisby A; Viaene AN; Santi M; Nasrallah M; Wang LP; Williams EA; Larque AB; Chebib I; Garcia BA; Wojcik JB
    Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2 expression in malignant peripheral nerve sheath tumour: a potential diagnostic pitfall associated with PRC2 inactivation.
    Odeyemi OO; Ozawa MG; Charville GW
    Histopathology; 2022 May; 80(6):995-1000. PubMed ID: 35122289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-based classification of benign and malignant peripheral nerve sheath tumors.
    Röhrich M; Koelsche C; Schrimpf D; Capper D; Sahm F; Kratz A; Reuss J; Hovestadt V; Jones DT; Bewerunge-Hudler M; Becker A; Weis J; Mawrin C; Mittelbronn M; Perry A; Mautner VF; Mechtersheimer G; Hartmann C; Okuducu AF; Arp M; Seiz-Rosenhagen M; Hänggi D; Heim S; Paulus W; Schittenhelm J; Ahmadi R; Herold-Mende C; Unterberg A; Pfister SM; von Deimling A; Reuss DE
    Acta Neuropathol; 2016 Jun; 131(6):877-87. PubMed ID: 26857854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant Peripheral Nerve Sheath Tumors Show Decreased Global DNA Methylation.
    Nix JS; Haffner MC; Ahsan S; Hicks J; De Marzo AM; Blakeley J; Raabe EH; Rodriguez FJ
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):958-963. PubMed ID: 30169729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Owosho AA; Estilo CL; Huryn JM; Chi P; Antonescu CR
    Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.
    Mito JK; Qian X; Doyle LA; Hornick JL; Jo VY
    Am J Clin Pathol; 2017 Aug; 148(2):179-189. PubMed ID: 28898989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
    Høland M; Berg KCG; Eilertsen IA; Bjerkehagen B; Kolberg M; Boye K; Lingjærde OC; Guren TK; Mandahl N; van den Berg E; Palmerini E; Smeland S; Picci P; Mertens F; Sveen A; Lothe RA
    EBioMedicine; 2023 Nov; 97():104829. PubMed ID: 37837931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeted therapy for malignant peripheral nerve sheath tumor: translational research and clinical application].
    Liao ZC; Zhang C; Liu XY; Ren ZW; Xu J; Zhang CZ; Yang Y; Zhu Z; Yang JL
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):648-653. PubMed ID: 31550853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.
    Prieto-Granada CN; Wiesner T; Messina JL; Jungbluth AA; Chi P; Antonescu CR
    Am J Surg Pathol; 2016 Apr; 40(4):479-89. PubMed ID: 26645727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignant peripheral nerve sheath tumors: case reports and a literature review].
    Konovalov NA; Korolishin VA; Asyutin DS; Timonin SY; Shults MA; Solenkova AV; Zakirov BA; Batyrov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(3):64-72. PubMed ID: 31339498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature.
    McComb EN; McComb RD; DeBoer JM; Neff JR; Bridge JA
    Cancer Genet Cytogenet; 1996 Oct; 91(1):8-12. PubMed ID: 8908161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant peripheral nerve sheath tumors.
    Gupta G; Maniker A
    Neurosurg Focus; 2007 Jun; 22(6):E12. PubMed ID: 17613203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.
    Asano N; Yoshida A; Ichikawa H; Mori T; Nakamura M; Kawai A; Hiraoka N
    Histopathology; 2017 Feb; 70(3):385-393. PubMed ID: 27580378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.
    Suresh K; Kliot T; Piunti A; Kliot M
    Surg Neurol Int; 2016; 7(Suppl 33):S797-S800. PubMed ID: 27920939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.